Upgrade to SI Premium - Free Trial

Amgen (AMGN) PT Raised to $180 at UBS Following Solid 2Q

July 26, 2017 8:34 AM
UBS raised its price target on Amgen (NASDAQ: AMGN) to $180.00 (from $175.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles